-
Je něco špatně v tomto záznamu ?
Structure-based specificity mapping of secreted aspartic proteases of Candida parapsilosis, Candida albicans, and Candida tropicalis using peptidomimetic inhibitors and homology modeling
F Majer, L Pavlickova, P Majer, M Hradilek, E Dolejsi, O Hruskova-Heidingsfeldova, I Pichova
Jazyk angličtina Země Německo
- MeSH
- aspartátové endopeptidasy chemie účinky léků MeSH
- Candida enzymologie MeSH
- financování organizované MeSH
- inhibitory proteas farmakologie chemická syntéza chemie MeSH
- izoenzymy chemie účinky léků MeSH
- molekulární konformace MeSH
- molekulární modely MeSH
- molekulární sekvence - údaje MeSH
- sekvence aminokyselin MeSH
- sekvenční homologie aminokyselin MeSH
- stereoizomerie MeSH
- substrátová specifita MeSH
- terciární struktura proteinů MeSH
- vztahy mezi strukturou a aktivitou MeSH
Secreted aspartic proteases (Saps) of pathogenic Candida spp. represent a specific target for antifungal drug development. We synthesized a series of peptidomimetic inhibitors with different isosteric groups and modifications at individual positions and tested them with purified Saps from C. albicans (Sap2p), C. tropicalis (Sapt1p), and C. parapsilosis (Sapp1p). The kinetic parameters indicated that all three proteases prefer binding of inhibitors containing bulky hydrophobic residues between positions P3 and P3'. The most divergent specificity was found for Sapp1p. The sequence alignment of Sap2p, Sapt1p, and Sapp1p, and homology modeling of Sapp1p with the crystal structure of Sapt1p and the complex of Sap2p with a peptidomimetic inhibitor showed that the overall folds of Sap2p, Sapt1p, and Sapp1p are similar. However, the N- and C-terminal loops formed by disulfide bonds between residues 47-53 and 258-292 are significantly shorter in Sapp1p, and a unique insertion following Tyr 129 in Sapp1p results in the formation of a loop that can interact with inhibitor residues. These Sapp1p structural differences might lead to its altered susceptibility to inhibition.
- 000
- 00000naa 2200000 a 4500
- 001
- bmc10026717
- 003
- CZ-PrNML
- 005
- 20120510102114.0
- 008
- 101029s2006 gw e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Majer, Filip $7 xx0156567
- 245 10
- $a Structure-based specificity mapping of secreted aspartic proteases of Candida parapsilosis, Candida albicans, and Candida tropicalis using peptidomimetic inhibitors and homology modeling / $c F Majer, L Pavlickova, P Majer, M Hradilek, E Dolejsi, O Hruskova-Heidingsfeldova, I Pichova
- 314 __
- $a Department of Protein Biochemistry, Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Flemingovo n. 2, CZ-166 10 Prague 6, Czech Republic.
- 520 9_
- $a Secreted aspartic proteases (Saps) of pathogenic Candida spp. represent a specific target for antifungal drug development. We synthesized a series of peptidomimetic inhibitors with different isosteric groups and modifications at individual positions and tested them with purified Saps from C. albicans (Sap2p), C. tropicalis (Sapt1p), and C. parapsilosis (Sapp1p). The kinetic parameters indicated that all three proteases prefer binding of inhibitors containing bulky hydrophobic residues between positions P3 and P3'. The most divergent specificity was found for Sapp1p. The sequence alignment of Sap2p, Sapt1p, and Sapp1p, and homology modeling of Sapp1p with the crystal structure of Sapt1p and the complex of Sap2p with a peptidomimetic inhibitor showed that the overall folds of Sap2p, Sapt1p, and Sapp1p are similar. However, the N- and C-terminal loops formed by disulfide bonds between residues 47-53 and 258-292 are significantly shorter in Sapp1p, and a unique insertion following Tyr 129 in Sapp1p results in the formation of a loop that can interact with inhibitor residues. These Sapp1p structural differences might lead to its altered susceptibility to inhibition.
- 650 _2
- $a sekvence aminokyselin $7 D000595
- 650 _2
- $a aspartátové endopeptidasy $x chemie $x účinky léků $7 D016282
- 650 _2
- $a Candida $x enzymologie $7 D002175
- 650 _2
- $a izoenzymy $x chemie $x účinky léků $7 D007527
- 650 _2
- $a molekulární modely $7 D008958
- 650 _2
- $a molekulární konformace $7 D008968
- 650 _2
- $a molekulární sekvence - údaje $7 D008969
- 650 _2
- $a inhibitory proteas $x farmakologie $x chemická syntéza $x chemie $7 D011480
- 650 _2
- $a terciární struktura proteinů $7 D017434
- 650 _2
- $a sekvenční homologie aminokyselin $7 D017386
- 650 _2
- $a stereoizomerie $7 D013237
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 650 _2
- $a substrátová specifita $7 D013379
- 650 _2
- $a financování organizované $7 D005381
- 700 1_
- $a Pavlíčková, Libuše. $7 _AN054697
- 700 1_
- $a Majer, Pavel $7 xx0063146
- 700 1_
- $a Hradilek, Martin $7 xx0076906
- 700 1_
- $a Dolejší, Elena $7 xx0075718
- 700 1_
- $a Hrušková-Heidingsfeldová, Olga $7 xx0060514
- 700 1_
- $a Pichová, Iva $7 xx0101840
- 773 0_
- $w MED00005521 $t Biological chemistry $g Roč. 387, č. 9 (2006), s. 1247-1254 $x 1431-6730
- 910 __
- $a ABA008 $b x $y 7
- 990 __
- $a 20101029110441 $b ABA008
- 991 __
- $a 20120510102047 $b ABA008
- 999 __
- $a ok $b bmc $g 801824 $s 666580
- BAS __
- $a 3
- BMC __
- $a 2006 $b 387 $c 9 $d 1247-1254 $i 1431-6730 $m Biological chemistry $n Biol Chem $x MED00005521
- LZP __
- $a 2010-B3/vtme